UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis

Chiaravalloti, ND; Amato, MP; Brichetto, G; Chataway, J; Dalgas, U; DeLuca, J; Meza, C; ... Feinstein, A; + view all (2020) The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. Journal of Neurology , 268 (5) pp. 1598-1607. 10.1007/s00415-020-10160-7. Green open access

[thumbnail of Chataway_The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis_AAM2.pdf]
Preview
Text
Chataway_The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis_AAM2.pdf - Accepted Version

Download (460kB) | Preview

Abstract

OBJECTIVE: Individuals with pre-existing chronic illness have shown increased anxiety and depression due to COVID-19. Here, we examine the impact of the COVID-19 pandemic on emotional symptomatology and quality of life in individuals with Progressive Multiple Sclerosis (PMS). METHODS: Data were obtained during a randomized clinical trial on rehabilitation taking place at 11 centers in North America and Europe. Participants included 131 individuals with PMS. Study procedures were interrupted in accordance with governmental restrictions as COVID-19 spread. During study closure, a COVID Impact Survey was administered via telephone or email to all participants, along with measures of depressive symptoms, anxiety symptoms, quality of life, and MS symptomatology that were previously administered pre-pandemic. RESULTS: 4% of respondents reported COVID-19 infection. No significant changes were noted in anxiety, quality of life, or the impact of MS symptomatology on daily life from baseline to lockdown. While total HADS-depression scores increased significantly at follow-up, this did not translate into more participants scoring above the HADS threshold for clinically significant depression. No significant relationships were noted between disease duration, processing speed ability or EDSS, and changes in symptoms of depression or anxiety. Most participants reported the impact of the virus on their psychological well-being, with a little impact on financial well-being. The perceived impact of the pandemic on physical and psychological well-being was correlated with the impact of MS symptomatology on daily life, as well as changes in depression. CONCLUSIONS: Overall, little change was noted in symptoms of depression or anxiety or overall quality of life

Type: Article
Title: The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s00415-020-10160-7
Publisher version: https://doi.org/10.1007/s00415-020-10160-7
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: COVID-19, Depression, Anxiety, Progressive multiple sclerosis, Quality of life
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10135443
Downloads since deposit
92Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item